medicine to prevent macular degeneration
For the wet form of macular degeneration, injections of Macugen, Lucentis, Avastin or Eylea are made directly into the eye. The above-mentioned cancer drug Avastin is considerably less expensive and appears to produce similar results in macular degeneration treatment, though it is not FDA-approved for this use. The Lucentis vs. Avastin debate continues while an ongoing clinical trial compares outcomes and safety of the two treatments.